10 Drug Approvals That Changed the Future of Medicine

7 Common Questions About Ofev

Ofev (nintedanib) is a treatment used for patients with idiopathic pulmonary fibrosis (IPF).  It is an anti-fibrotic drug that was approved by the FDA in October 2014 to help slow down the progression of the disease. Here are some of the most frequently asked questions about Ofev from the manufacturers, Boehringer Ingelheim. How…

Bellerophon’s INOpulse Inhaled Nitrous Oxide Device Improves Symptoms of PH-IPF Patients, Study Finds

INOpulse has shown promise in treating patients with pulmonary hypertension associated with idiopathic pulmonary fibrosis (PH-IPF), concludes a study by Bellerophon Therapeutics, developer of the inhaled nitrous oxide device. The study, “Unraveling the Mode of Action of Pulsed Inhaled NO in Severe IPF Using Functional Respiratory Imaging.” showed that PH-IPF…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums